Last reviewed · How we verify
NCT04462887
Nursing Interventions Following Sudden Cardiac Arrest
NA trial testing Nursing intervention program in ICD in 168 participants. Completed in 31 December 2003.
31 December 2003
Quick facts
| Lead sponsor | University of Washington |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 168 |
| Start date | 1 January 1998 |
| Primary completion | 31 December 2003 |
| Estimated completion | 31 December 2003 |
Drugs / interventions tested
- Nursing intervention program
Conditions studied
- ICD — all drugs for ICD →
Sponsor
University of Washington
Who can join
21 and older, any sex, with ICD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Determine the benefits of implantable cardioverter defibrillator (ICD) patients participating in a structured, 8-week educational telephone intervention delivered by expert cardiovascular nurses post-ICD. To determine if individuals participating in a post-hospital telephone nursing intervention would demonstrate (1) increased physical functioning, (2) increased psychological adjustment, (3) improved self-efficacy in managing the challenges of ICD recovery, and (4) lower levels of health care utilization over usual care at 1, 3, 6 and 12 months post-ICD implantation.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Physical function, psychological adjustment, and self-efficacy following sudden cardiac arrest and an initial implantable cardioverter defibrillator (ICD) in a social cognitive theory intervention: secondary analysis of a randomized control trial.
Dougherty CM, Liberato ACS, Streur MM, Burr RL, et al · · 2022 · cited 4× · PMID 35948889 · DOI 10.1186/s12872-022-02782-8 -
Social Determinants of Health-Related Outcomes in an Intervention Following Initial Implantable Cardioverter-Defibrillator Implantation.
Streur MM, Auld JP, Chang WL, Choupani F, et al · · 2025 · cited 2× · PMID 40365845 · DOI 10.1161/jaha.124.039238 -
Physical Function, Psychological Adjustment, and Self-Efficacy Following Sudden Cardiac Arrest and an Initial Implantable Cardioverter Defibrillator (ICD) in a Social Cognitive Theory Intervention: Secondary Analysis of a Randomized Control Trial
Dougherty CM, Liberato ACS, Streur MM, Burr RL, et al · · 2022 · DOI 10.21203/rs.3.rs-1182256/v1
Verify or expand the search:
- PubMed search for NCT04462887
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ICD
Currently open trials in the same condition.
- NCT07372196 — Left Bundle Branch Pacing in Patients With Hypertrophic Cardiomyopathy After Myectomy · NA · recruiting
- NCT07342036 — Prospective Study of Lead-associated Tricuspid Regurgitation in Patients Undergoing New Transvalvular Lead Insertion · recruiting
- NCT06520150 — Evaluation of the Effectiveness of Two Methods of Regional Anesthesia During S-ICD Implantation Procedure. · NA · recruiting
- NCT04499326 — Improving Patient Reported Outcome Measures in Catheter Ablation · NA · recruiting
- NCT05835791 — END - VT Cohort Study · recruiting
Other University of Washington trials
Trials by the same sponsor.
- NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
- NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
- NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
- NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
- NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04462887 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Washington
- Last refreshed: 8 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04462887.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing